Deacetylase Inhibitor News and Research

RSS
New research finds how cancer cells acquire resistance to molecular-targeted drugs

New research finds how cancer cells acquire resistance to molecular-targeted drugs

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Novel drug combination could enhance immunotherapy responses in patients with lung cancer

Radiotherapy plus panobinostat more effective for aggressive, recurrent brain cancer

Radiotherapy plus panobinostat more effective for aggressive, recurrent brain cancer

Researchers use stem cell-derived 'mini-brains' to identify drug candidate for rare neurological disorder

Researchers use stem cell-derived 'mini-brains' to identify drug candidate for rare neurological disorder

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

FDA accepts Mundipharma EDO's Investigational New Drug Application for EDO-S101

Novartis presents positive Phase III results of Farydak therapy at EHA

Novartis presents positive Phase III results of Farydak therapy at EHA

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Novel therapeutic approaches to improve thyroid cancer outcomes

Novel therapeutic approaches to improve thyroid cancer outcomes

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

FDA grants Breakthrough Therapy designation to Syndax's entinostat for ER+ breast cancer

Researchers discover new approach to treat two lethal metastatic cancers

Researchers discover new approach to treat two lethal metastatic cancers

Lymphoma drug dislodges hidden virus in HIV patients

Lymphoma drug dislodges hidden virus in HIV patients

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

MD Anderson initiates Phase 1/2 entinostat-lapatinib ditosylate combination study in metastatic breast cancer

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

NYUCI experts present latest research findings about hematologic cancers at 53rd ASH meeting

Vorinostat in addition to chemotherapy drugs improves remission rates in AML patients

Vorinostat in addition to chemotherapy drugs improves remission rates in AML patients

Researchers show how ER-positive breast cancer tumors become resistant to tamoxifen

Researchers show how ER-positive breast cancer tumors become resistant to tamoxifen

Combination of azacitidine and entinostat shows promise against NSCLC

Combination of azacitidine and entinostat shows promise against NSCLC

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

Syndax receives European patent allowance for entinostat to treat metastatic breast cancer

Syndax receives U.S. patent for entinostat to treat metastatic cancers

Syndax receives U.S. patent for entinostat to treat metastatic cancers

Epigenetic therapy holds promise for cancer management

Epigenetic therapy holds promise for cancer management

Epigenetic-molecular targeted therapy combination holds promise against advanced lung cancer

Epigenetic-molecular targeted therapy combination holds promise against advanced lung cancer